These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26970660)

  • 1. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.
    Vasilakaki S; Barbayianni E; Leonis G; Papadopoulos MG; Mavromoustakos T; Gelb MH; Kokotos G
    Bioorg Med Chem; 2016 Apr; 24(8):1683-95. PubMed ID: 26970660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A
    Smyrniotou A; Kokotou MG; Mouchlis VD; Barbayianni E; Kokotos G; Dennis EA; Constantinou-Kokotou V
    Bioorg Med Chem; 2017 Feb; 25(3):926-940. PubMed ID: 28034646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulations reveal structural insights into inhibitor binding modes and functionality in human Group IIA phospholipase A
    Kim RR; Malde AK; Nematollahi A; Scott KF; Church WB
    Proteins; 2017 May; 85(5):827-842. PubMed ID: 28056488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A
    Mouchlis VD; Morisseau C; Hammock BD; Li S; McCammon JA; Dennis EA
    Bioorg Med Chem; 2016 Oct; 24(20):4801-4811. PubMed ID: 27320659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.
    Mouchlis VD; Michopoulou V; Constantinou-Kokotou V; Mavromoustakos T; Dennis EA; Kokotos G
    J Chem Inf Model; 2012 Jan; 52(1):243-54. PubMed ID: 22196172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Dual Inhibitor of Secreted Phospholipase A
    Theodoropoulou MA; Koutoulogenis GS; Zhang L; Akrani I; Mikros E; Hilgenfeld R; Kokotos G
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of secreted phospholipase A2 suppress the release of PGE2 in renal mesangial cells.
    Vasilakaki S; Barbayianni E; Magrioti V; Pastukhov O; Constantinou-Kokotou V; Huwiler A; Kokotos G
    Bioorg Med Chem; 2016 Jul; 24(13):3029-3034. PubMed ID: 27234891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
    Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
    Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A One Pot Synthesis of Novel Bioactive Tri-Substitute-Condensed-Imidazopyridines that Targets Snake Venom Phospholipase A2.
    Anilkumar NC; Sundaram MS; Mohan CD; Rangappa S; Bulusu KC; Fuchs JE; Girish KS; Bender A; Basappa ; Rangappa KS
    PLoS One; 2015; 10(7):e0131896. PubMed ID: 26196520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
    Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
    J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
    Wang P; Li Y; Shao Q; Zhou W; Wang K
    J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Amberlyst-15 mediated synthesis of novel thienyl-pyrazole carboxamides that potently inhibit Phospholipase A2 by binding to an allosteric site on the enzyme.
    Kumar AD; Prabhudeva MG; Bharath S; Kumara K; Lokanath NK; Kumar KA
    Bioorg Chem; 2018 Oct; 80():444-452. PubMed ID: 29986189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
    Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
    J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
    Qiu S; Chen F; Liu Y; Lai L
    Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides.
    Stephens D; Barbayianni E; Constantinou-Kokotou V; Peristeraki A; Six DA; Cooper J; Harkewicz R; Deems RA; Dennis EA; Kokotos G
    J Med Chem; 2006 May; 49(9):2821-8. PubMed ID: 16640343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAR study on inhibitors of GIIA secreted phospholipase A
    Zhang S; Li Y; Qin Z; Tu G; Chen G; Yan A
    Chem Biol Drug Des; 2019 May; 93(5):666-684. PubMed ID: 30582300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
    Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2-oxoamides based on sulfonamide analogs of gamma-amino acids and their activity on phospholipase A2.
    Antonopoulou G; Magrioti V; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
    J Pept Sci; 2008 Oct; 14(10):1111-20. PubMed ID: 18618424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual analysis of structurally diverse synthetic analogs as inhibitors of snake venom secretory phospholipase A2.
    Sivaramakrishnan V; Ilamathi M; Ghosh KS; Sathish S; Gowda TV; Vishwanath BS; Rangappa KS; Dhananjaya BL
    J Mol Recognit; 2016 Jan; 29(1):22-32. PubMed ID: 26218369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
    Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
    Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.